Skip to content
10-Q

Quarterly Report

ADMA BIOLOGICS, INC. ADMA

0001140361-26-019336

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 231.77M sh
Shares Diluted Q1 2026 · Mar 31, 2026 239.96M sh
Shares Diluted Q1 2026 · Mar 31, 2025 244.68M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $130.19M
Stock Repurchased Q1 2026 · Mar 31, 2025 $0
Capex Q1 2026 · Mar 31, 2026 $2.54M
Capex Q1 2026 · Mar 31, 2025 $4.7M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $58.25M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$19.68M
Long Term Debt Q1 2026 · Mar 31, 2026 $193.58M
Long Term Debt Q1 2026 · Dec 31, 2025 $69.33M
Short Term Debt Q1 2026 · Mar 31, 2026 $3.28M
Short Term Debt Q1 2026 · Dec 31, 2025 $2.81M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $138.15M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $87.63M
Stockholders Equity Q1 2026 · Mar 31, 2026 $390.33M
Stockholders Equity Q1 2026 · Dec 31, 2025 $477.32M
Stockholders Equity Q1 2026 · Mar 31, 2025 $373.42M
Stockholders Equity Q1 2026 · Dec 31, 2024 $349.02M
Current Liabilities Q1 2026 · Mar 31, 2026 $73.54M
Current Liabilities Q1 2026 · Dec 31, 2025 $69.54M
Total Liabilities Q1 2026 · Mar 31, 2026 $274.86M
Total Liabilities Q1 2026 · Dec 31, 2025 $146.92M
Current Assets Q1 2026 · Mar 31, 2026 $511.17M
Current Assets Q1 2026 · Dec 31, 2025 $466.51M
Total Assets Q1 2026 · Mar 31, 2026 $665.18M
Total Assets Q1 2026 · Dec 31, 2025 $624.24M
Total Assets Q1 2026 · Mar 31, 2025 $510.57M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.19
Eps Diluted Q1 2026 · Mar 31, 2025 $0.11
Eps Basic Q1 2026 · Mar 31, 2026 $0.19
Eps Basic Q1 2026 · Mar 31, 2025 $0.11
Sga Expense Q1 2026 · Mar 31, 2026 $26.74M
Sga Expense Q1 2026 · Mar 31, 2025 $24.08M
Rd Expense Q1 2026 · Mar 31, 2026 $2.6M
Rd Expense Q1 2026 · Mar 31, 2025 $826K
Net Income Q1 2026 · Mar 31, 2026 $45.33M
Net Income Q1 2026 · Mar 31, 2025 $26.9M
Operating Income Q1 2026 · Mar 31, 2026 $58.27M
Operating Income Q1 2026 · Mar 31, 2025 $34.88M
Gross Profit Q1 2026 · Mar 31, 2026 $80.75M
Gross Profit Q1 2026 · Mar 31, 2025 $61.1M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $33.74M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $53.71M
Revenue Q1 2026 · Mar 31, 2026 $114.49M
Revenue Q1 2026 · Mar 31, 2025 $114.8M